Occam Places Aimee Einstein as VP of People & Culture at SI-BONE
SI-BONE is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. The company went public in 2018 with a successful $108M IPO on the NASDAQ. Early-stage investors included Orbimed, Novo A/S, Skyline Ventures and Foresite Capital.
Occam placed Aimee Einstein as VP of People and Culture in August 2022. Aimee is an HR leader who brings over a decade of leadership & development experience within a biotech company of consequence. Prior to her pivot to HR, she was a marketing executive at both large public, and small entrepreneurial companies.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.